Cite
HARVARD Citation
Bar-Gil Shitrit, A. et al. (n.d.). P571 Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study. Journal of Crohn's and colitis. pp. S399-S400. [Online].